ENDRA Life Sciences Inc (NASDAQ: NDRA) kicked off on Friday, up 3.04% from the previous trading day, before settling in for the closing price of $0.12. Over the past 52 weeks, NDRA has traded in a range of $0.07-$2.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.00%. While this was happening, its average annual earnings per share was recorded 85.44%. With a float of $70.12 million, this company’s outstanding shares have now reached $70.27 million.
Let’s determine the extent of company efficiency that accounts for 21 employees.
ENDRA Life Sciences Inc (NDRA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of ENDRA Life Sciences Inc is 0.21%, while institutional ownership is 3.79%.
ENDRA Life Sciences Inc (NDRA) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 3/31/2024, the organization reported -0.43 earnings per share (EPS), higher than consensus estimate (set at -0.55) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.44% per share during the next fiscal year.
ENDRA Life Sciences Inc (NASDAQ: NDRA) Trading Performance Indicators
Take a look at ENDRA Life Sciences Inc’s (NDRA) current performance indicators. Last quarter, stock had a quick ratio of 1.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.23, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.17 in one year’s time.
Technical Analysis of ENDRA Life Sciences Inc (NDRA)
Looking closely at ENDRA Life Sciences Inc (NASDAQ: NDRA), its last 5-days average volume was 75.55 million, which is a jump from its year-to-date volume of 9.4 million. As of the previous 9 days, the stock’s Stochastic %D was 43.27%. Additionally, its Average True Range was 0.04.
During the past 100 days, ENDRA Life Sciences Inc’s (NDRA) raw stochastic average was set at 4.37%, which indicates a significant decrease from 26.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 482.22% in the past 14 days, which was higher than the 218.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2411, while its 200-day Moving Average is $0.8975. However, in the short run, ENDRA Life Sciences Inc’s stock first resistance to watch stands at $0.1354. Second resistance stands at $0.1488. The third major resistance level sits at $0.1603. If the price goes on to break the first support level at $0.1105, it is likely to go to the next support level at $0.0990. Now, if the price goes above the second support level, the third support stands at $0.0856.
ENDRA Life Sciences Inc (NASDAQ: NDRA) Key Stats
The company with the Market Capitalisation of 8.58 million has total of 11,036K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -10,060 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,780 K.
